omeprazole has been researched along with Infectious Diseases in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Omeprazole is a mainstay of therapy for gastroesophageal reflux disease (GERD) and gastritis, and is increasingly used as an over-the-counter remedy for dyspepsia." | 7.76 | Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. ( Blass, AL; Kohler, JE; Liu, J; Soybel, DI; Tai, K, 2010) |
"Omeprazole is a mainstay of therapy for gastroesophageal reflux disease (GERD) and gastritis, and is increasingly used as an over-the-counter remedy for dyspepsia." | 3.76 | Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. ( Blass, AL; Kohler, JE; Liu, J; Soybel, DI; Tai, K, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kohler, JE | 1 |
Blass, AL | 1 |
Liu, J | 1 |
Tai, K | 1 |
Soybel, DI | 1 |
1 other study available for omeprazole and Infectious Diseases
Article | Year |
---|---|
Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis.
Topics: Ammonium Chloride; Animals; Anti-Ulcer Agents; Antioxidants; Cell Death; Cells, Cultured; Communicab | 2010 |